The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Oral Topotecan Versus Intravenous Docetaxel In Pretreated, Advanced Non-Small Cell Lung Cancer
Official Title: An Open-Label, Multicentre, Randomised, Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non Small Cell Lung Cancer
Study ID: NCT00049998
Brief Summary: The purpose of this study is to collect information on how effective and how well tolerated an oral investigational drug is compared to a standard intravenous drug in patients with pretreated, advanced non-small lung cancer (NSCLC).
Detailed Description:
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
GSK Investigational Site, Adelaide, South Australia, Australia
GSK Investigational Site, Bedford Park, South Australia, Australia
GSK Investigational Site, Melbourne, Victoria, Australia
GSK Investigational Site, Ringwood East, Victoria, Australia
GSK Investigational Site, Innsbruck, , Austria
GSK Investigational Site, St Poelten, , Austria
GSK Investigational Site, Vienna, , Austria
GSK Investigational Site, Braasschaat, , Belgium
GSK Investigational Site, Bruxelles, , Belgium
GSK Investigational Site, Edegem, , Belgium
GSK Investigational Site, Liege, , Belgium
GSK Investigational Site, Sydney, Nova Scotia, Canada
GSK Investigational Site, Oshawa, Ontario, Canada
GSK Investigational Site, Thunder Bay, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Greenfield Park, Quebec, Canada
GSK Investigational Site, Montreal, Quebec, Canada
GSK Investigational Site, Sainte-Foy, Quebec, Canada
GSK Investigational Site, Xian, Shaanxi, China
GSK Investigational Site, Beijing, , China
GSK Investigational Site, Shanghai, , China
GSK Investigational Site, Shanghai, , China
GSK Investigational Site, Tianjin, , China
GSK Investigational Site, Wangfujing, Beijing, , China
GSK Investigational Site, Ceske Budejovice, , Czech Republic
GSK Investigational Site, Kladno, , Czech Republic
GSK Investigational Site, Praha 4, , Czech Republic
GSK Investigational Site, Herlev, , Denmark
GSK Investigational Site, Odense C, , Denmark
GSK Investigational Site, Helsinki, , Finland
GSK Investigational Site, Turku, , Finland
GSK Investigational Site, Caen Cedex 5, , France
GSK Investigational Site, Dijon Cedex, , France
GSK Investigational Site, Strasbourg Cedex, , France
GSK Investigational Site, Toulon Naval, , France
GSK Investigational Site, Vesoul Cedex, , France
GSK Investigational Site, Gauting, Bayern, Germany
GSK Investigational Site, Muenchen, Bayern, Germany
GSK Investigational Site, Regensburg, Bayern, Germany
GSK Investigational Site, Treuenbrietzen, Brandenburg, Germany
GSK Investigational Site, Leipzig, Sachsen, Germany
GSK Investigational Site, Bad Berka, Thueringen, Germany
GSK Investigational Site, Berlin, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Athens, , Greece
GSK Investigational Site, Heraklion, Crete, , Greece
GSK Investigational Site, Papagos, Athens, , Greece
GSK Investigational Site, Rio, Patras, , Greece
GSK Investigational Site, Thessaloniki, , Greece
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Csorna, , Hungary
GSK Investigational Site, Miskolc, , Hungary
GSK Investigational Site, Ashkelon, , Israel
GSK Investigational Site, Beer-Sheva, , Israel
GSK Investigational Site, Ramat Gan, , Israel
GSK Investigational Site, Tel Aviv, , Israel
GSK Investigational Site, Roma, Lazio, Italy
GSK Investigational Site, Torino, Piemonte, Italy
GSK Investigational Site, Sassari, Sardegna, Italy
GSK Investigational Site, Perugia, Umbria, Italy
GSK Investigational Site, Verona, Veneto, Italy
GSK Investigational Site, Riga, , Latvia
GSK Investigational Site, Riga, , Latvia
GSK Investigational Site, Kaunas, , Lithuania
GSK Investigational Site, Vilnius, , Lithuania
GSK Investigational Site, 's-HERTOGENBOSCH, , Netherlands
GSK Investigational Site, Delft, , Netherlands
GSK Investigational Site, Groningen, , Netherlands
GSK Investigational Site, Heerlen, , Netherlands
GSK Investigational Site, Leeuwarden, , Netherlands
GSK Investigational Site, Newtown, Wellington, , New Zealand
GSK Investigational Site, Quezon City, , Philippines
GSK Investigational Site, Poznan, , Poland
GSK Investigational Site, Warszawa, , Poland
GSK Investigational Site, Lisboa, , Portugal
GSK Investigational Site, Porto, , Portugal
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, N. Novgorod, , Russian Federation
GSK Investigational Site, Samara, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, Singapore, , Singapore
GSK Investigational Site, Pretoria, Gauteng, South Africa
GSK Investigational Site, Cape Town, Western Province, South Africa
GSK Investigational Site, Port Elizabeth, , South Africa
GSK Investigational Site, Barakaldo (Vizcaya), , Spain
GSK Investigational Site, Jaen, , Spain
GSK Investigational Site, La Laguna (Santa Cruz de Tenerife), , Spain
GSK Investigational Site, Lerida, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Madrid, , Spain
GSK Investigational Site, Malaga, , Spain
GSK Investigational Site, Palma de Mallorca, , Spain
GSK Investigational Site, Pontevedra, , Spain
GSK Investigational Site, Valencia, , Spain
GSK Investigational Site, Zurich, , Switzerland
GSK Investigational Site, Taipei, , Taiwan
GSK Investigational Site, Tau-Yuan County, , Taiwan
GSK Investigational Site, Bangkok, , Thailand
GSK Investigational Site, Chiang Mai, , Thailand
GSK Investigational Site, Istanbul, , Turkey
GSK Investigational Site, Izmir, , Turkey
GSK Investigational Site, Kharkov, , Ukraine
GSK Investigational Site, Lugansk, , Ukraine
GSK Investigational Site, Lvov, , Ukraine
GSK Investigational Site, Dundee, Forfarshire, United Kingdom
GSK Investigational Site, Glasgow, Lanarkshire, United Kingdom
GSK Investigational Site, Leicester, Leicestershire, United Kingdom
GSK Investigational Site, Nottingham, Nottinghamshire, United Kingdom
GSK Investigational Site, Guildford, Surrey, United Kingdom
GSK Investigational Site, London, , United Kingdom
Name: GSK Clinical Trials, MD
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR